Avinger announces $5 million registered direct and private placement offerings, priced at-the-market under nasdaq rules

Redwood city, ca / accesswire / august 4, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that it has entered into a definitive agreement with a single, healthcare-focused institutional investor for the sale and issuance of 1,484,019 shares of the company's common stock (or pre-funded warrants in lieu thereof), in a registered direct offering priced at-the-market under nasdaq rules. concurrently with the registered direct offering, the company entered into a definitive agreement with the investor in the registered direct offering for the sale and issuance of 1,369,864 shares of common stock (or pre-funded warrants in lieu thereof) in a private placement priced at-the-market under nasdaq rules.
AVGR Ratings Summary
AVGR Quant Ranking